New weapon against superbugs tested in chinese hospitals
NCT ID NCT07268560
Summary
This study is collecting real-world information on how well a newly approved antibiotic combination works against dangerous, antibiotic-resistant bacterial infections in Chinese hospitals. Researchers will follow about 100 adult patients with serious abdominal or lung infections who receive this new drug. The goal is to understand how effective the treatment is in everyday hospital practice and how it affects patient recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA ( VAP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sir Run Run Shaw Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.